BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21392639)

  • 1. Clopidogrel-drug interactions.
    Bates ER; Lau WC; Angiolillo DJ
    J Am Coll Cardiol; 2011 Mar; 57(11):1251-63. PubMed ID: 21392639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel.
    Ma TK; Lam YY; Tan VP; Kiernan TJ; Yan BP
    Pharmacol Ther; 2010 Feb; 125(2):249-59. PubMed ID: 19919843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clopidogrel and proton pump inhibitors--boon or bane?].
    Labenz J; Meyners W; Petersen KU
    Dtsch Med Wochenschr; 2010 Feb; 135(5):203-6. PubMed ID: 20104441
    [No Abstract]   [Full Text] [Related]  

  • 5. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonresponders to clopidogrel: pharmacokinetics and interactions involved.
    Giorgi MA; Di Girolamo G; González CD
    Expert Opin Pharmacother; 2010 Oct; 11(14):2391-403. PubMed ID: 20828266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between statins and clopidogrel: is there anything clinically relevant?
    Bhindi R; Ormerod O; Newton J; Banning AP; Testa L
    QJM; 2008 Dec; 101(12):915-25. PubMed ID: 18676683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
    Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
    Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interaction between clopidogrel and proton pump inhibitors.
    Liu TJ; Jackevicius CA
    Pharmacotherapy; 2010 Mar; 30(3):275-89. PubMed ID: 20180611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors and clopidogrel.
    Gaglia MA; Waksman R
    Cardiovasc Ther; 2010 Jun; 28(3):169-76. PubMed ID: 20345494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors in patients treated with aspirin and clopidogrel after acute coronary syndrome.
    Gaspar A; Ribeiro S; Nabais S; Rocha S; Azevedo P; Pereira MA; Brandāo A; Salgado A; Correia A
    Rev Port Cardiol; 2010 Oct; 29(10):1511-20. PubMed ID: 21265493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of clopidogrel and statins: a hypothetical interaction or therapeutic dilemma?
    Tafreshi MJ; Zagnoni LG; Gentry EJ
    Pharmacotherapy; 2006 Mar; 26(3):388-94. PubMed ID: 16503718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance.
    Hulot JS; Collet JP; Montalescot G
    Curr Cardiol Rep; 2011 Oct; 13(5):451-8. PubMed ID: 21826477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.
    Juhász M; Herszényi L; Tulassay Z
    Digestion; 2010; 81(1):10-5. PubMed ID: 20029203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel resistance: identifying and overcoming a barrier to effective antiplatelet treatment.
    Uchiyama S
    Cardiovasc Ther; 2011 Dec; 29(6):e100-11. PubMed ID: 21883990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation.
    Rossini R; Capodanno D; Musumeci G; Lettieri C; Lortkipanidze N; Romano M; Nijaradze T; Tarantini G; Cicorella N; Sirbu V; Guagliumi G; Rosiello R; Valsecchi O; Gavazzi A
    Coron Artery Dis; 2011 May; 22(3):199-205. PubMed ID: 21358542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and clopidogrel: is it a significant drug interaction?
    Oyetayo OO; Talbert RL
    Expert Opin Drug Saf; 2010 Jul; 9(4):593-602. PubMed ID: 20377472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, drug metabolism, and safety of prasugrel and clopidogrel.
    Achar S
    Postgrad Med; 2011 Jan; 123(1):73-9. PubMed ID: 21293086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.